Bayer's experimental Parkinson’s disease therapy made from stem cells will soon enter late-stage studies, marking a key test for regenerative medicine in neurologic conditions.
The therapy, known as bemdaneprocel, is being developed by BlueRock Therapeutics ...
↧
